文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

血清脂蛋白(a)水平与钙化性主动脉瓣狭窄严重程度及预后的关联:一项中国队列研究

Association of serum lipoprotein(a) level with the severity and prognosis of calcific aortic valve stenosis: a Chinese cohort study.

作者信息

Liu Shuo-Lin, Rozi Rynat, Shi Hui-Wei, Gao Ying, Guo Yuan-Lin, Tang Yi-Da, Li Jian-Jun, Wu Na-Qiong

机构信息

Endocrinology & Cardiometabolic Center, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

出版信息

J Geriatr Cardiol. 2020 Mar;17(3):133-140. doi: 10.11909/j.issn.1671-5411.2020.03.009.


DOI:10.11909/j.issn.1671-5411.2020.03.009
PMID:32280329
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7118012/
Abstract

BACKGROUND: There was a causal relationship between elevated lipoprotein(a) [Lp(a)] levels and increased risk of calcific aortic valve stenosis (CAVS) in whites and blacks. The present study aimed to investigate whether Lp(a) levels were associated with aortic stenosis (AS) severity and clinical events in Chinese patients. METHODS: Levels of serum Lp(a) were measured in 652 patients with CAVS, whom all underwent baseline echocardiographic examination. The clinical endpoint was defined as a composite of aortic valve replacement (AVR) and cardiac death. RESULTS: Patients in the tertile 3 of Lp(a) had a higher percentage of severe AS compared with those in the tertile 1 and 2 of Lp(a) (46.2% 33.9%, = 0.005). Moreover, the top tertile of Lp(a) was an independent predictor of severe AS (OR = 1.78, 95% CI: 1.18-2.66, = 0.006). However, there was no significant association between tertile 3 of Lp(a) and clinical events (hazard ratio: 0.73; 95% CI: 0.43-1.24; = 0.239) in the multivariate Cox regression analysis during a mean follow-up time of 3.16 ± 2.74 years. CONCLUSIONS: Elevated Lp(a) level was an independent predictor of severe AS by echocardiography in the Chinese population, but was not associated with the increased risk of AVR and cardiac death, suggesting that Lp(a) levels might be helpful in the risk stratification of patients with CAVS.

摘要

背景:在白人和黑人中,脂蛋白(a)[Lp(a)]水平升高与钙化性主动脉瓣狭窄(CAVS)风险增加之间存在因果关系。本研究旨在调查Lp(a)水平与中国患者主动脉狭窄(AS)严重程度及临床事件是否相关。 方法:对652例CAVS患者进行血清Lp(a)水平检测,所有患者均接受了基线超声心动图检查。临床终点定义为主动脉瓣置换(AVR)和心源性死亡的复合终点。 结果:与Lp(a)处于第一和第二三分位数的患者相比,Lp(a)处于第三三分位数的患者重度AS的比例更高(46.2%对33.9%,P=0.005)。此外,Lp(a)最高三分位数是重度AS的独立预测因素(OR=1.78,95%CI:1.18-2.66,P=0.006)。然而,在平均随访时间为3.16±2.74年的多变量Cox回归分析中,Lp(a)第三三分位数与临床事件之间无显著相关性(风险比:0.73;95%CI:0.43-1.24;P=0.239)。 结论:在中国人群中,Lp(a)水平升高是经超声心动图诊断的重度AS的独立预测因素,但与AVR和心源性死亡风险增加无关,这表明Lp(a)水平可能有助于CAVS患者的风险分层。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/165f/7118012/737c579a40e8/jgc-17-03-133-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/165f/7118012/73549122fe54/jgc-17-03-133-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/165f/7118012/8d173fe9a41b/jgc-17-03-133-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/165f/7118012/92c8aa82ddf1/jgc-17-03-133-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/165f/7118012/575f685c9537/jgc-17-03-133-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/165f/7118012/737c579a40e8/jgc-17-03-133-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/165f/7118012/73549122fe54/jgc-17-03-133-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/165f/7118012/8d173fe9a41b/jgc-17-03-133-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/165f/7118012/92c8aa82ddf1/jgc-17-03-133-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/165f/7118012/575f685c9537/jgc-17-03-133-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/165f/7118012/737c579a40e8/jgc-17-03-133-g005.jpg

相似文献

[1]
Association of serum lipoprotein(a) level with the severity and prognosis of calcific aortic valve stenosis: a Chinese cohort study.

J Geriatr Cardiol. 2020-3

[2]
Genetic Variation in LPA, Calcific Aortic Valve Stenosis in Patients Undergoing Cardiac Surgery, and Familial Risk of Aortic Valve Microcalcification.

JAMA Cardiol. 2019-7-1

[3]
Association of Mild to Moderate Aortic Valve Stenosis Progression With Higher Lipoprotein(a) and Oxidized Phospholipid Levels: Secondary Analysis of a Randomized Clinical Trial.

JAMA Cardiol. 2018-12-1

[4]
Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis.

J Am Coll Cardiol. 2019-5-7

[5]
Lipoprotein(a) and Its Autoantibodies in Association with Calcific Aortic Valve Stenosis.

Diseases. 2023-3-3

[6]
Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis.

J Am Coll Cardiol. 2015-9-15

[7]
Autotaxin interacts with lipoprotein(a) and oxidized phospholipids in predicting the risk of calcific aortic valve stenosis in patients with coronary artery disease.

J Intern Med. 2016-5-30

[8]
Lipoprotein-associated phospholipase A2 activity, genetics and calcific aortic valve stenosis in humans.

Heart. 2020-9

[9]
The Prevalence of Lipoprotein(a) Measurement and Degree of Elevation Among 2710 Patients With Calcific Aortic Valve Stenosis in an Academic Echocardiography Laboratory Setting.

Angiology. 2017-10

[10]
Lipoprotein Proteomics and Aortic Valve Transcriptomics Identify Biological Pathways Linking Lipoprotein(a) Levels to Aortic Stenosis.

Metabolites. 2021-7-16

引用本文的文献

[1]
Lipoprotein(a) and calcific aortic valve disease initiation and progression: a systematic review and meta-analysis.

Cardiovasc Res. 2023-7-6

[2]
Lipoprotein(a) and Cardiovascular Disease in Chinese Population: A Beijing Heart Society Expert Scientific Statement.

JACC Asia. 2022-11-15

本文引用的文献

[1]
Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis.

J Am Coll Cardiol. 2019-5-7

[2]
Association of Mild to Moderate Aortic Valve Stenosis Progression With Higher Lipoprotein(a) and Oxidized Phospholipid Levels: Secondary Analysis of a Randomized Clinical Trial.

JAMA Cardiol. 2018-12-1

[3]
Role of lipoprotein (a) and LPA KIV2 repeat polymorphism in bicuspid aortic valve stenosis and calcification: a proof of concept study.

Intern Emerg Med. 2018-8-11

[4]
Lipoprotein(a) Induces Human Aortic Valve Interstitial Cell Calcification.

JACC Basic Transl Sci. 2017-8-28

[5]
Pathological significance of lipoprotein(a) in aortic valve stenosis.

Atherosclerosis. 2018-3-15

[6]
Lipoprotein(a) Associated Molecules are Prominent Components in Plasma and Valve Leaflets in Calcific Aortic Valve Stenosis.

JACC Basic Transl Sci. 2017-6

[7]
The Role of Lipoprotein(a) in Calcific Aortic Valve Disease: Insights From a Large-Cohort Genetic Study.

JAMA Cardiol. 2018-1-1

[8]
OxLDL-derived lysophosphatidic acid promotes the progression of aortic valve stenosis through a LPAR1-RhoA-NF-κB pathway.

Cardiovasc Res. 2017-9-1

[9]
Recommendations on the Echocardiographic Assessment of Aortic Valve Stenosis: A Focused Update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography.

J Am Soc Echocardiogr. 2017-4

[10]
Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study.

Eur Heart J. 2016-12-14

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索